161 related articles for article (PubMed ID: 12112414)
1. Dopamine transporter-dependent induction of C-Fos in HEK cells.
Yatin SM; Miller GM; Norton C; Madras BK
Synapse; 2002 Jul; 45(1):52-65. PubMed ID: 12112414
[TBL] [Abstract][Full Text] [Related]
2. Dopamine and norepinephrine transporter-dependent c-Fos production in vitro: relevance to neuroadaptation.
Yatin SM; Miller GM; Madras BK
J Neurosci Methods; 2005 Apr; 143(1):69-78. PubMed ID: 15763138
[TBL] [Abstract][Full Text] [Related]
3. Amphetamine regulation of dopamine transport. Combined measurements of transporter currents and transporter imaging support the endocytosis of an active carrier.
Kahlig KM; Javitch JA; Galli A
J Biol Chem; 2004 Mar; 279(10):8966-75. PubMed ID: 14699142
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
[TBL] [Abstract][Full Text] [Related]
5. Differential psychostimulant-induced activation of neural circuits in dopamine transporter knockout and wild type mice.
Trinh JV; Nehrenberg DL; Jacobsen JP; Caron MG; Wetsel WC
Neuroscience; 2003; 118(2):297-310. PubMed ID: 12699766
[TBL] [Abstract][Full Text] [Related]
6. The dopamine transporter expression level differentially affects responses to cocaine and amphetamine.
Cagniard B; Sotnikova TD; Gainetdinov RR; Zhuang X
J Neurogenet; 2014; 28(1-2):112-21. PubMed ID: 24673634
[TBL] [Abstract][Full Text] [Related]
7. Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine.
Kahlig KM; Galli A
Eur J Pharmacol; 2003 Oct; 479(1-3):153-8. PubMed ID: 14612146
[TBL] [Abstract][Full Text] [Related]
8. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications.
Volkow ND; Wang GJ; Fowler JS; Logan J; Franceschi D; Maynard L; Ding YS; Gatley SJ; Gifford A; Zhu W; Swanson JM
Synapse; 2002 Mar; 43(3):181-7. PubMed ID: 11793423
[TBL] [Abstract][Full Text] [Related]
9. Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.
Houlihan WJ; Kelly L; Pankuch J; Koletar J; Brand L; Janowsky A; Kopajtic TA
J Med Chem; 2002 Sep; 45(19):4097-109. PubMed ID: 12213053
[TBL] [Abstract][Full Text] [Related]
10. Fluctuation of the dopamine uptake inhibition potency of cocaine, but not amphetamine, at mammalian cells expressing the dopamine transporter.
Ukairo OT; Ramanujapuram S; Surratt CK
Brain Res; 2007 Feb; 1131(1):68-76. PubMed ID: 17169338
[TBL] [Abstract][Full Text] [Related]
11. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding.
Rothman RB; Dersch CM; Carroll FI; Ananthan S
Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522
[TBL] [Abstract][Full Text] [Related]
12. A triple mutation in the second transmembrane domain of mouse dopamine transporter markedly decreases sensitivity to cocaine and methylphenidate.
Chen R; Han DD; Gu HH
J Neurochem; 2005 Jul; 94(2):352-9. PubMed ID: 15998286
[TBL] [Abstract][Full Text] [Related]
13. Cocaine induction of dopamine transporter trafficking to the plasma membrane.
Little KY; Elmer LW; Zhong H; Scheys JO; Zhang L
Mol Pharmacol; 2002 Feb; 61(2):436-45. PubMed ID: 11809869
[TBL] [Abstract][Full Text] [Related]
14. Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism.
Saunders C; Ferrer JV; Shi L; Chen J; Merrill G; Lamb ME; Leeb-Lundberg LM; Carvelli L; Javitch JA; Galli A
Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6850-5. PubMed ID: 10823899
[TBL] [Abstract][Full Text] [Related]
15. Changes in dopamine transporter and c-Fos expression in the nucleus accumbens of alcohol-tolerant rats.
Yoshimoto K; Ueda S; Nishi M; Yang Y; Matsushita H; Takeuchi Y; Kato B; Kawai Y; Noritake K; Kaneda S; Sorimachi Y; Yasuhara M
Alcohol Clin Exp Res; 2000 Mar; 24(3):361-5. PubMed ID: 10776677
[TBL] [Abstract][Full Text] [Related]
16. Regulation of amphetamine-stimulated dopamine efflux by protein kinase C beta.
Johnson LA; Guptaroy B; Lund D; Shamban S; Gnegy ME
J Biol Chem; 2005 Mar; 280(12):10914-9. PubMed ID: 15647254
[TBL] [Abstract][Full Text] [Related]
17. Amphetamine-induced dopamine efflux. A voltage-sensitive and intracellular Na+-dependent mechanism.
Khoshbouei H; Wang H; Lechleiter JD; Javitch JA; Galli A
J Biol Chem; 2003 Apr; 278(14):12070-7. PubMed ID: 12556446
[TBL] [Abstract][Full Text] [Related]
18. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.
Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA
J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422
[TBL] [Abstract][Full Text] [Related]
19. Protein tyrosine kinase inhibitors alter human dopamine transporter activity in Xenopus oocytes.
Doolen S; Zahniser NR
J Pharmacol Exp Ther; 2001 Mar; 296(3):931-8. PubMed ID: 11181926
[TBL] [Abstract][Full Text] [Related]
20. Benzo- and cyclohexanomazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.
Houlihan WJ; Ahmad UF; Koletar J; Kelly L; Brand L; Kopajtic TA
J Med Chem; 2002 Sep; 45(19):4110-8. PubMed ID: 12213054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]